Influence of ions, pH and crowding agents on structure and stability of PIM1 secondary structures

İrem Göller1, Saba Orouji1, Özgül Persil Çetinkol1

  • 1Department of Chemistry, Middle East Technical University, Çankaya, 06800, Ankara, Turkey.

Biochimie
|May 14, 2026
PubMed

Insights

Triple Negative Breast Cancer (TNBC) is aggressive, lacking targeted therapies. PIM1 oncogene structures, like G-quadruplexes, show promise as new TNBC therapeutic targets, with stability influenced by pH, ions, and crowding.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Triple Negative Breast Cancer (TNBC) lacks ER, PR, and HER-2 receptors, limiting targeted therapy options.
  • PIM1 oncogenes are overexpressed in TNBC, and contain G-quadruplex-duplex hybrid (QDH) structures with therapeutic potential.
  • Understanding DNA secondary structures in PIM1 is crucial for developing novel TNBC treatments.

Purpose of the Study:

  • To investigate the in vitro effects of pH, ions (K+, Na+), and molecular crowding on PIM1 secondary structures (G-quadruplex, i-motif, dsDNA).
  • To assess the stability and coexistence of these structures under various conditions relevant to the tumor microenvironment.
  • To provide insights for designing small molecules targeting PIM1 structures for TNBC therapy.

Main Methods:

  • Polyacrylamide Gel Electrophoresis (PAGE)
  • UV-Vis Spectroscopy
  • Circular Dichroism (CD) Spectroscopy

Main Results:

  • G-quadruplex (G4), i-motif (iM), and double helical DNA (dsDNA) structures derived from PIM1 sequences are stable and can coexist, particularly in acidic conditions.
  • Lower pH stabilizes iM structures; K+ ions stabilize G4 structures more than Na+ ions.
  • Molecular crowding stabilizes G4 structures, alters G4 conformation cation-dependently, and affects iM and dsDNA stability based on molecular weight.

Conclusions:

  • PIM1 secondary structures (G4, iM, dsDNA, QDH) exhibit stability under varying pH, ionic, and molecular crowding conditions.
  • These findings support the potential of targeting PIM1 structures, including QDHs, for TNBC treatment.
  • Modulating these DNA structures could lead to new anticancer therapeutic strategies against TNBC.